Find More Contacts for Omthera Pharmaceuticals
Protected Content
Director
1 email found
View contacts for Omthera Pharmaceuticals to access new leads and connect with decision-makers.
View All Contacts
  • Phone Number 908-741-4399

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients

who have elevated triglyceride levels and increased risk of cardiovascular disease.

Lists Featuring This Company

Closed United States Health Care Companies
6,888 Number of Organizations • $67.7B Total Funding Amount • 6,740 Number of Investors
Biotechnology Companies that Exited
7,141 Number of Organizations • $724.4B Total Funding Amount • 19,865 Number of Investors
Health Care Companies that Exited (Top 10K)
9,989 Number of Organizations • $791.6B Total Funding Amount • 22,478 Number of Investors
Closed Northeastern US Companies (Top 10K)
9,747 Number of Organizations • $88.4B Total Funding Amount • 12,804 Number of Investors
Omthera Pharmaceuticals was acquired by AstraZeneca for $323M on May 29, 2013.

Frequently Asked Questions

Where is Omthera Pharmaceuticals's headquarters? Omthera Pharmaceuticals is located in Princeton, New Jersey, United States.Who invested in Omthera Pharmaceuticals? Omthera Pharmaceuticals has 2 investors including New Enterprise Associates and Sofinnova Partners.How much funding has Omthera Pharmaceuticals raised to date? Omthera Pharmaceuticals has raised .When was the last funding round for Omthera Pharmaceuticals? Omthera Pharmaceuticals closed its last funding round on Feb 28, 2013 from a Debt Financing round.